Possible effects of insulin-like growth factor-I, IGF-binding protein-3 and IGF-1/IGFBP-3 molar ratio on mammographic density: A cross-sectional study

European Journal of Gynaecological Oncology

Volumn 33, Issue 1, 2012, Pages 74-78

  Meggiorini, M L ^a   Cipolla, V ^a   Borgoni, G ^a   Nofroni, I ^a   Pala, A ^a   De Felice, C ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Breast cancer risk; IGF 1; IGF 1 IGFBP 3; IGFBP 3; Mammographic density; Molar ratio

Indexed keywords

SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADULT; ARTICLE; BREAST CANCER; CANCER RISK; FEMALE; HORMONE BLOOD LEVEL; HORMONE DETERMINATION; HUMAN; ITALY; MAJOR CLINICAL STUDY; MAMMOGRAPHY; POSTMENOPAUSE; PREMENOPAUSE; STATISTICAL ANALYSIS; BLOOD; BREAST; BREAST TUMOR; CROSS-SECTIONAL STUDY; HISTOLOGY; METABOLISM; MIDDLE AGED; RADIOGRAPHY; RISK FACTOR;

ADULT; BREAST; BREAST NEOPLASMS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; MAMMOGRAPHY; MIDDLE AGED; POSTMENOPAUSE; PREMENOPAUSE; RISK FACTORS;

EID: 84860570055     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Wood T.L., Yee D.: "Introduction: IGFs and IGFBPs in the normal mammary gland and in breast cancer". J. Mammary Gland. Biol. Neoplasia, 2000, 5, 1.
2. Sachdev D., Yee D.: "The IGF system and breast cancer". Endocr. Relat. Cancer, 2001, 8, 197.
3. Mikami K., Ozasa K., Nakao M., Miki T., Hayashi K., Watanabe Y. et al., JACC Study Group: "Prostate cancer risk in relation to insulin-like growth factor (IGF)-I and IGF-binding protein-3: A nested case-control study in large scale cohort study in Japan". Asian Pac. J. Cancer Prev., 2009, 10 (suppl.), 57.
4. Bostedt K.T., Schmid C., Ghirlanda-Keller C., Olie R., Winterhalter KH, Zapf J.: "Insulin-like growth factor (IGF) I down-regulates type 1 IGF receptor (IGF 1R) and reduces the IGF I response in A549 non-small-cell lung cancer and Saos-2/B-10 osteoblastic osteosarcoma cells". Exp. Cell Res., 2001, 271, 368.
5. Li B.D., Khosravi M.J., Berkel H.J., Diamandi A., Dayton M.A., Smith M.H.: "Free insulin-like growth factor-I and breast cancer risk". Int. J. Cancer, 2001, 91, 736.
6. Pollak M.N., Schernhammer E.S., Hankinson S.E.: "Insulin-like growth factors and neoplasia". Nat. Rev. Cancer, 2004, 4, 505.
7. O'Han M.K., Baxter R.C., Schedlich L.J.: "Effects of endogenous insulin-like growth factor binding protein-3 on cell cycle regulation in breast cancer cells". Growth Factors, 2009, 12, 1.
8. Helle S.I.: "The insulin-like growth factor system in advanced breast cancer". Best. Pract. Clin. Endocrinol. Metab., 2004, 18, 67.
9. Jerome L., Shiry L., Leyland-Jones B.: "Anti-insulin-like growth factor strategies in breast cancer". Semin. Oncol., 2004, 31, 54.
10. Firth S.M., Baxter R.C.: "Cellular actions of the insulin-like growth factor binding proteins". Endocr. Rev., 2002, 23, 824.
11. Siwanowicz I., Popowicz G.M., Wisniewska M., Huber R., Kuenkele K.P., Lang K. et al.: "Structural basis for the regulation of insulin-like growth factors by IGF binding proteins". Structure, 2005, 13, 155.
12. Endogenous Hormones and Breast Cancer Collaborative Group, Key T.J., Appleby P.N., Reeves G.K., Roddam A.W.: "Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies". Lancet Oncol., 2010, 11, 530.
13. Baglietto L., Dallas R. English, Hopper J.L., Morris H.A., Tilley W.D., Giles G.G.: "Circulating insulin-like growth factor-I and binding protein-3 and the risk of breast cancer". Cancer Epidemiol. Biomarkers Prev., 2007, 16, 763.
14. Taverne C.W., Verheus M., McKay J.D., Kaaks R., Canzian F., Grobbee D.E. et al.: "Common genetic variation of insulin-like growth factor-binding protein 1 (IGFBP-1), IGFBP-3, and acid labile subunit in relation to serum IGF-I levels and mammographic density". Breast Cancer Res. Treat., 2010, 123, 843.
15. Shi R., Yu H., McLarty J., Glass J.: "IGF-1 and breast cancer: a meta-analysis". Int. J. Cancer, 2004, 111, 418.
16. Mathews L., Schneider S.S.: "Insulin-like growth factor-I inhibits growth regulatory responses engaged by estrogen and progesterone in the mouse mammary gland". Eur. J. Cancer Prev., 2008, 17, 297.
17. Johansson H., Gandini S., Bonanni B., Mariette F., Guerrieri-Gonzaga A., Serrano D. et al.: "Relationships between circulating hormone levels, mammographic percent density and breast cancer risk factors in postmenopausal women". Breast Cancer Res. Treat., 2008, 108, 57.
18. Schernhammer E.S., Holly J.M., Pollak M.N., Hankinson S.: "Circulating levels of insulin-like growth Factors, their Binding Proteins, and breast cancer risk". Cancer Epidemiol Biomarkers Prev., 2005, 14.
19. Schernhammer E.S., Holly J.M., Hunter D.J., Pollak M.N., Hankinson S.E.: "Insulin-like growth factor-I, its binding proteins (IGFBP-1 and IGFBP-3), and growth hormone and breast cancer risk in The Nurses Health Study II". Endocrine-related Cancer, 2006, 13, 583.
20. Harvey J.A., Bovbjerg V.E.: "Quantitative assessment of mammographic breast density: relationship with breast cancer risk". Radiology, 2004, 230, 29.
21. Boyd N.F., Guo H., Martin L.J., Sun L., Stone J., Fishell E. et al.: "Mammographic density and the risk and detection of breast cancer". N. Engl. J. Med., 2007, 356, 227.
22. Vachon M.C., van Gils C.H., Sellers T.A., Ghosh K., Pruthi S., Brandt K.R., Pankratz V.S.: "Mammographic density, breast cancer risk and risk prediction". Breast Cancer Res., 2007, 9, 217.
23. Boyd N.F., Rommens J.M., Vogt K., Lee V., Hopper J.L., Yaffe M.J., Paterson A.D.: "Mammographic breast density as an intermediate phenotype for breast cancer". Lancet Oncol., 2005, 6, 798.
24. McCormack V.A., dos Santos Silva I.: "Breast density and parenchymal patterns as markers of breast cancer risk: a metaanalysis". Cancer Epidemiol. Biomarkers Prev. 2006, 15, 1159.
25. Byrne C., Colditz G.A., Willett W.C., Speizer F.E., Pollk M., Hankinson S.E.: "Plasma insulin growth factor (IGF-I), IGF-binding protein 3, and mammographic density". Cancer Res., 2000, 60, 3744.
26. Diorio C., Pollak M., Byrne C., Mâsse B., Herbert-Croteau N., Yaffe M. et al.: "Insulin-like growth factor-1, IGF-binding protein-3, and mammographic breast density". Cancer Epidemiol. Biomarkers Prev., 2005, 14, 1065.
27. Maskarinec G., Williams A.E., Kaas R.: "A cross-sectional investigation of breast density and insulin-like growth factor I". Int. J. Cancer, 2003, 107, 991.
28. dos Santos Silva I., Johnson N., De Stavola B., Torres-Mejìa G., Fletcher O., Allen N.E. et al:. "The insulin-like growth factor system and mammographic features in premenopausal and postmenopausal women". Cancer Epidemiol. Biomarkers Prev., 2006, 15, 449.
29. Bremnes Y., Ursin G., Bjurstam N., Rinaldi S., Kaaks R., Gram I.T.: "Endogenous sex hormones, prolactin and mammographic density in postmenopausal Norwegian women. International journal of cancer". Int. J. Cancer, 2007, 121, 2506.
30. Bremnes Y., Ursin G., Bjurstam N., Rinaldi S., Kaaks R., Gram I.T.: "Insulin-like growth factor and mammographic density in postmenopausal Norwegian women". Cancer Epidemiol. Biomarkers Prev., 2007, 16, 57.
31. Aiello E.J., Tworoger S.S., Yasui Y., Stanczyk F.Z., Potter J., Ulrich C.M. et al.: "Associations among circulating sex hormones, insulin-like growth factor, lipids, and mammographic density in postmenopausal women". Cancer Epidemiol. Biomarkers Prev., 2005, 14, 1411.
32. Liberman L., Menell J.H.: "Breast imaging reporting and data system (BIRADS)". Radiol. Clin. North Am., 2002, 40, 409.
33. Balleyguier C., Ayadi S., Nguyen K.V., Vanel D., Dromain C., Sigal R.: "BIRADSTM classification in mammography". EJR, 2007, 61, 192.
34. Yu H., Jin F., Shu X.O., Li B.D., Dai Q., Cheng J.R. et al.: "Insulin-like growth factors and breast cancer risk in Chinese women". Cancer Epidemiol. Biomarkers Prev., 2002, 11, 705.
35. Maskarinec G., Takata Y., Chen Z., Gram I.T., Nagata C., Pagano I. et al.: "IGF-I and mammographic density in four geographic locations: a pooled analysis". Int. J. Cancer, 2007, 121, 1786.
36. Campagnoli C., Abbà C., Ambroggio S., Peris C.: "Differential effects of progestins on the circulating IGF-I system". Maturitas, 2003, 10, 46 (suppl. 1), S39.
37. Chia V.M., Newcomb P.A., White E., Zheng Y., Potter J.D., Lampe J.W.: "Reproducibility of serum leptin, insulin-like growth factor-I, and insulin-like growth factor-binding protein-3 measurements". Horm. Res., 2008, 69, 295.
38. Borofsky N.D., Vogelman J.H., Krajcik R.A., Orentreich N.: "Utility of insulin-like growth factor-1 as a biomarker in epidemiological studies". Clin. Chem., 2002, 48, 2248.
39. Milani D., Carmichael J.D., Welkowitz J., Ferris S., Reitz R.E., Danoff A., Kleinberg D.L.: "Variability and reliability of single serum IGF -measurements: impact on determining predictability of risk ratios in disease development". J. Clin. Endocrinol. Metab., 2004, 89, 2271.
40. Dabrosin C.: "Increase of free insulin-like growth factor-1 in normal human breast in vivo late in menstrual cycle". Breast Cancer Res. Treat., 2003, 50, 193.
41. Friedrich N., Krebs A., Nauck M., Wallaschofski H.: "Age- and gender-specific reference ranges for serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 concentrations on the Immulite 2500: results of the Study of Health in Pomerania (SHIP)". Clin. Chem. Lab. Med., 2010, 48, 115.
42. Yaffe M.J.: "Mammographic density. Measurement of mammographic density". Breast Cancer Res., 2008, 10, 209.
43. Martin L.J., Melnichouk O., Guo H., Chiarelli A.M., Hislop TG., Yaffe M.J. et al.: "Family history, mammographic density, and risk of breast cancer". Cancer Epidemiol. Biomarkers Prev., 2010, 19, 456.
44. Boyd N.F., Lockwood G.A., Martin L.J., Byng J.W., Yaffe M.J., Tritchler D.L.: "Mammographic density as a marker of susceptibility to breast cancer: a hypothesis". IARC Sci. Publ., 2001, 154, 163.
45. Diorio C., Brisson J., Bérubé S., Pollak M.: "Genetic polymorphisms involved in insulin-like growth factor (IGF) pathway in relation to mammographic breast density and IGF levels". Cancer Epidemiol. Biomarkers Prev., 2008, 17, 880.
46. Diorio C., Brisson J., Bérubé S., Pollak M.: "Intact and total insulin-like growth factor-binding protein-3 (IGFBP-3) levels in relation to breast cancer risk factors: a cross-sectional study". Breast Cancer Res., 2008, 10, R42.